Floatz logo

Nigella Sativ

Hypercholesterolemia

Aga Khan UniversityPhase 1/2Dormant
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Hypercholesterolemia cohort.

Asset / SponsorPhaseRating
Ezetimibe
Punjab Institute of Cardology
Phase 4BBB
Lipitor
Punjab Institute of Cardology
Phase 4BBB
SIMVASTATIN
paresh Dandona
Phase 4BBB
PITAVASTATIN
JW Pharmaceutical
Phase 4BBB
Rosuvastatin
Sanofi
Phase 4BB

View all 36 →

Same molecule, other indications

Nigella Sativ is also rated in:

abdominal obesity-metabolic syndromeDormant
CCC
Indicative ·
52 / 100
View asset →
diabetes mellitusDormant
CCC
Indicative ·
50 / 100
View asset →
hypertensive disorderDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →